Previous close | 10.55 |
Open | 10.46 |
Bid | 10.24 x 100 |
Ask | 10.32 x 100 |
Day's range | 10.27 - 10.66 |
52-week range | 9.93 - 32.00 |
Volume | |
Avg. volume | 439,986 |
Market cap | 591.335M |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 10.70 |
EPS (TTM) | 0.96 |
Earnings date | 09 May 2024 |
Forward dividend & yield | 0.60 (5.69%) |
Ex-dividend date | 27 Feb 2024 |
1y target est | 16.50 |
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events: 2024 BofA Securities Healthcare Conference Management will host a fireside session on Thursday, May 16, 2024, at 10:00 a.m. Pacific Time (PT) at the Encore Hotel in Las Vegas. Audio webcasts of the presentations will be accessible under the “News &
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2024 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, May 9, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live